Simon J. Littlewood
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Simon J. Littlewood has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Rene Michael Botnar
School of Biomedical Engineering and Imaging Sciences King's College London London UK
3 shared publications - Claudia Prieto
School of Biomedical Engineering and Imaging Sciences King's College London London UK
2 shared publications Karl P. Kunze
School of Biomedical Engineering and Imaging Sciences, King's College London, London, United Kingdom; MR Research Collaborations, Siemens Healthcare Limited, Camberley, United Kingdom
2 shared publications- Michael G. Crabb
School of Biomedical Engineering and Imaging Sciences King's College London London UK
2 shared publications Anastasia Fotaki
School of Biomedical Engineering and Imaging Sciences, King's College London, London, United Kingdom
1 shared publication- Anastasia Fotaki
School of Biomedical Engineering and Imaging Sciences King's College London London UK
1 shared publication
Latest Publications
- Open Access
- 13 January 2026
- Published by Elsevier in Journal of Cardiovascular Magnetic Resonance
- Vol. 28 (1) , 102688
Simultaneous bright- and black-blood three-dimensional whole-heart magnetic resonance imaging for integrated coronary plaque detection and luminal stenosis assessment: A prospective comparison with coronary computed tomography angiography
- 13 January 2026
- Published by Elsevier in Journal of Cardiovascular Magnetic Resonance
- Vol. 28 (1) , 102688
Open AccessSimultaneous bright- and black-blood three-dimensional whole-heart magnetic resonance imaging for integrated coronary plaque detection and luminal stenosis assessment: A prospective comparison with coronary computed tomography angiography
- Open Access
- 22 December 2025
- Published by Wiley in NMR in Biomedicine
- Vol. 39 (2) , e70195
3D Whole‐Heart Joint T 1 /T 1ρ Mapping and Water‐Fat Imaging on a Clinical 0.55‐T Low‐Field Scanner
Myocardial maps are conventionally acquired in 2D breath‐hold single‐parameter scans that are slow and have limited heart coverage. To overcome limitations associated with 2D breath‐hold mapping sequences, we develop a novel free‐breathing 3D joint / mapping sequence with Dixon encoding to provide co‐registered 3D and maps and water‐fat volumes with isotropic spatial resolution in a single scan for comprehensive contrast‐agent free myocardial tissue characterization and visualisation of the whole‐heart anatomy on a clinical 0.55‐T MR scanner. The proposed sequence acquires four interleaved 3D volumes with preparation modules to provide and encoding, with data acquired with a two‐echo Dixon readout and 2D image navigators to enable respiratory scan efficiency. Images were reconstructed with nonrigid respiratory motion‐corrected iterative SENSE with multi‐dimensional low‐rank patch‐based denoising, and maps generated by matching with simulated dictionaries. The proposed sequence was tested in phantoms, 11 healthy subjects and 1 patient, and compared with conventional techniques. For phantoms, the proposed 3D and measurements showed good correlation with 2D spin‐echo reference measurements. For healthy subjects, septal myocardial tissue mapping values were and for the proposed sequence, against and for 2D modified Look‐Locker inversion recovery and 2D respectively. Promising results were obtained when the proposed mapping was compared to 2D late‐gadolinium enhancement imaging in a patient. The proposed approach enables simultaneous 3D whole‐heart joint / mapping and water‐fat imaging at 0.55 T in a single scan of min, demonstrating good agreement with conventional techniques in phantoms and healthy subjects, and promising results in a patient.
- 22 December 2025
- Published by Wiley in NMR in Biomedicine
- Vol. 39 (2) , e70195
Open Access3D Whole‐Heart Joint T 1 /T 1ρ Mapping and Water‐Fat Imaging on a Clinical 0.55‐T Low‐Field Scanner
Myocardial maps are conventionally acquired in 2D breath‐hold single‐parameter scans that are slow and have limited heart coverage. To overcome limitations associated with 2D breath‐hold mapping sequences, we develop a novel free‐breathing 3D joint / mapping sequence with Dixon encoding to provide co‐registered 3D and maps and water‐fat volumes with isotropic spatial resolution in a single scan for comprehensive contrast‐agent free myocardial tissue characterization and visualisation of the whole‐heart anatomy on a clinical 0.55‐T MR scanner. The proposed sequence acquires four interleaved 3D volumes with preparation modules to provide and encoding, with data acquired with a two‐echo Dixon readout and 2D image navigators to enable respiratory scan efficiency. Images were reconstructed with nonrigid respiratory motion‐corrected iterative SENSE with multi‐dimensional low‐rank patch‐based denoising, and maps generated by matching with simulated dictionaries. The proposed sequence was tested in phantoms, 11 healthy subjects and 1 patient, and compared with conventional techniques. For phantoms, the proposed 3D and measurements showed good correlation with 2D spin‐echo reference measurements. For healthy subjects, septal myocardial tissue mapping values were and for the proposed sequence, against and for 2D modified Look‐Locker inversion recovery and 2D respectively. Promising results were obtained when the proposed mapping was compared to 2D late‐gadolinium enhancement imaging in a patient. The proposed approach enables simultaneous 3D whole‐heart joint / mapping and water‐fat imaging at 0.55 T in a single scan of min, demonstrating good agreement with conventional techniques in phantoms and healthy subjects, and promising results in a patient.
- Open Access
- 21 February 2025
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 93 (6) , 2297-2310
3D joint T 1 /T 1 ρ /T 2 mapping and water‐fat imaging for contrast‐agent free myocardial tissue characterization at 1.5T
Purpose: To develop a novel, free‐breathing, 3D joint // mapping sequence with Dixon encoding to provide co‐registered 3D , , and maps and water‐fat volumes with isotropic spatial resolution in a single min scan for comprehensive contrast‐agent‐free myocardial tissue characterization and simultaneous evaluation of the whole‐heart anatomy. Methods: An interleaving sequence over 5 heartbeats is proposed to provide , , and encoding, with 3D data acquired with Dixon gradient‐echo readout and 2D image navigators to enable respiratory scan efficiency. Images were reconstructed with a non‐rigid motion‐corrected, low‐rank patch‐based reconstruction, and maps were generated through dictionary matching. The proposed sequence was compared against conventional 2D techniques in phantoms, 10 healthy subjects, and 1 patient. Results: The proposed 3D , , and measurements showed excellent correlation with 2D reference measurements in phantoms. For healthy subjects, the mapping values of septal myocardial tissue were , , and for the proposed sequence, against , , and for 2D MOLLI, 2D ‐prep bSSFP and 2D ‐prep bSSFP, respectively. Promising results were obtained when comparing the proposed mapping to 2D references in 1 patient with active myocarditis. Conclusion: The proposed approach enables simultaneous 3D whole‐heart joint // mapping and water/fat imaging in 7 min scan time, demonstrating good agreement with conventional mapping techniques in phantoms and healthy subjects and promising results in 1 patient with suspected cardiovascular disease.
- 21 February 2025
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 93 (6) , 2297-2310
Open Access3D joint T 1 /T 1 ρ /T 2 mapping and water‐fat imaging for contrast‐agent free myocardial tissue characterization at 1.5T
Purpose: To develop a novel, free‐breathing, 3D joint // mapping sequence with Dixon encoding to provide co‐registered 3D , , and maps and water‐fat volumes with isotropic spatial resolution in a single min scan for comprehensive contrast‐agent‐free myocardial tissue characterization and simultaneous evaluation of the whole‐heart anatomy. Methods: An interleaving sequence over 5 heartbeats is proposed to provide , , and encoding, with 3D data acquired with Dixon gradient‐echo readout and 2D image navigators to enable respiratory scan efficiency. Images were reconstructed with a non‐rigid motion‐corrected, low‐rank patch‐based reconstruction, and maps were generated through dictionary matching. The proposed sequence was compared against conventional 2D techniques in phantoms, 10 healthy subjects, and 1 patient. Results: The proposed 3D , , and measurements showed excellent correlation with 2D reference measurements in phantoms. For healthy subjects, the mapping values of septal myocardial tissue were , , and for the proposed sequence, against , , and for 2D MOLLI, 2D ‐prep bSSFP and 2D ‐prep bSSFP, respectively. Promising results were obtained when comparing the proposed mapping to 2D references in 1 patient with active myocarditis. Conclusion: The proposed approach enables simultaneous 3D whole‐heart joint // mapping and water/fat imaging in 7 min scan time, demonstrating good agreement with conventional mapping techniques in phantoms and healthy subjects and promising results in 1 patient with suspected cardiovascular disease.
- Open Access
- 27 August 2024
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 8 (9) , ytae458
Mesalazine-induced myocarditis in a patient with ulcerative colitis: a case report
Background: Mesalazine is an established first-line therapy for inflammatory bowel disease (IBD) and remains the mainstay of treatment for mild to moderate ulcerative colitis (UC). Both mesalazine and UC are rare but recognized causes of myopericarditis. Cardiac magnetic resonance (CMR) is a non-invasive method of assessing for myopericarditis. This case reports highlights the importance of early CMR in diagnosis, and management of myocarditis in a patient with IBD. Case summary: A 28-year-old male was admitted with a 2-day history of chest pain. Three weeks prior to this presentation, the patient was initiated on mesalazine for UC. Serum troponin T and C-reactive protein were elevated. An echocardiogram showed borderline low left ventricular systolic function (LVEF = 50–55%). A CMR showed extensive patchy late gadolinium enhancement (LGE) in the mid to epicardial basal and mid lateral wall. The findings were consistent with acute myocarditis, and a working diagnosis of mesalazine-induced myocarditis was made. Mesalazine was stopped and guideline-directed anti-inflammatories initiated. Oral prednisolone was also introduced for IBD control. Follow-up CMR at four months showed near complete resolution of LGE. Discussion: Myocarditis in the context of IBD may be infective, immune-mediated or due to mesalazine hypersensitivity. Histological conformation was not available in this case. This case report highlights the importance of access to early CMR in order establish the diagnosis and withdrawal of the culprit medication. In the majority of cases, CMR will replace the need for endomyocardial biopsy; however, this may still be required in the most severe cases.
- 27 August 2024
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 8 (9) , ytae458
Open AccessMesalazine-induced myocarditis in a patient with ulcerative colitis: a case report
Background: Mesalazine is an established first-line therapy for inflammatory bowel disease (IBD) and remains the mainstay of treatment for mild to moderate ulcerative colitis (UC). Both mesalazine and UC are rare but recognized causes of myopericarditis. Cardiac magnetic resonance (CMR) is a non-invasive method of assessing for myopericarditis. This case reports highlights the importance of early CMR in diagnosis, and management of myocarditis in a patient with IBD. Case summary: A 28-year-old male was admitted with a 2-day history of chest pain. Three weeks prior to this presentation, the patient was initiated on mesalazine for UC. Serum troponin T and C-reactive protein were elevated. An echocardiogram showed borderline low left ventricular systolic function (LVEF = 50–55%). A CMR showed extensive patchy late gadolinium enhancement (LGE) in the mid to epicardial basal and mid lateral wall. The findings were consistent with acute myocarditis, and a working diagnosis of mesalazine-induced myocarditis was made. Mesalazine was stopped and guideline-directed anti-inflammatories initiated. Oral prednisolone was also introduced for IBD control. Follow-up CMR at four months showed near complete resolution of LGE. Discussion: Myocarditis in the context of IBD may be infective, immune-mediated or due to mesalazine hypersensitivity. Histological conformation was not available in this case. This case report highlights the importance of access to early CMR in order establish the diagnosis and withdrawal of the culprit medication. In the majority of cases, CMR will replace the need for endomyocardial biopsy; however, this may still be required in the most severe cases.
- Open Access
- 20 May 2022
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 6 (5) , ytac208
A case report of cardiac cysticercosis in a returning traveller: a rare cause of myocarditis
A 38-year-old male of Indian origin presented via ambulance directly to the cardiac catheter lab with chest pain and electrocardiogram changes suggestive of an ST-elevation myocardial infarction. Serum troponin was recorded at >10 000 ng/L. Angiogram revealed normal coronary arteries. Echocardiography showed myocardial lesions and a subsequent cardiac magnetic resonance imaging showed myocardial cysticercosis. This is a case of myocardial cysticercosis causing myocarditis. He was treated successfully with albendazole for Taenia solium infection and non-steroidal anti-inflammatory drugs and colchicine for myocarditis.
- 20 May 2022
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 6 (5) , ytac208
Open AccessA case report of cardiac cysticercosis in a returning traveller: a rare cause of myocarditis
A 38-year-old male of Indian origin presented via ambulance directly to the cardiac catheter lab with chest pain and electrocardiogram changes suggestive of an ST-elevation myocardial infarction. Serum troponin was recorded at >10 000 ng/L. Angiogram revealed normal coronary arteries. Echocardiography showed myocardial lesions and a subsequent cardiac magnetic resonance imaging showed myocardial cysticercosis. This is a case of myocardial cysticercosis causing myocarditis. He was treated successfully with albendazole for Taenia solium infection and non-steroidal anti-inflammatory drugs and colchicine for myocarditis.